Equities

Integrated Diagnostics Holdings PLC

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Integrated Diagnostics Holdings PLC

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.615
  • Today's Change-0.01 / -1.60%
  • Shares traded18.44k
  • 1 Year change+66.22%
  • Beta0.2409
Data delayed at least 20 minutes, as of Feb 13 2026 16:17 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Integrated Diagnostics Holdings PLC is a diagnostics services provider. The Company operates in the Middle East and Africa with operations in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Company is engaged in offering services in immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, histopathology, genetics, radiology, and others. The Company’s brands include Al Borg, Al Borg Scan, Al Mokhtabar, Biolab, Echo-Lab, Ultralab, Al Mokhtabar Sudan and Biolab KSA. It operates through approximately 628 branches. It offers more than 3,000 diagnostics tests ranging from routine to advanced. Its common tests include those for cholesterol, diabetes, pregnancy, and substance abuse. Through Al Borg Scan, it offers a full range of radiology services, including magnetic resonance imaging (MRI), computed tomography (CT), electromyography, electrocardiogram (ECG), electroencephalogram (EEG), ultrasound, x-ray, mammograms and cath lab facilities, others.

  • Revenue in USD (TTM)144.54m
  • Net income in USD23.47m
  • Incorporated2014
  • Employees6.31k
  • Location
    Integrated Diagnostics Holdings PLC12 Castle StreetSAINT HELIER JE2 3RTJerseyJEY
  • Phone+44 1 534847000
  • Websitehttps://www.idhcorp.com/
More ▼

Institutional shareholders

8.50%Per cent of shares held by top holders
HolderShares% Held
Fidelity Management & Research Co. LLCas of 30 Nov 202519.82m3.41%
Norges Bank Investment Managementas of 30 Jun 202513.70m2.36%
RBC Global Asset Management (UK) Ltd.as of 30 Jun 20255.65m0.97%
Sanlam Investment Management (Pty) Ltd.as of 31 Dec 20244.50m0.77%
Handelsbanken Fonder ABas of 31 Jan 20261.46m0.25%
Lacuna Verm�gen GmbHas of 31 Dec 20241.23m0.21%
Dimensional Fund Advisors LPas of 30 Nov 20251.22m0.21%
IMPact SGR SpAas of 30 Sep 2025850.00k0.15%
S-Bank Fund Management Ltd.as of 30 Jun 2025550.40k0.10%
Rudiarius Capital Management (Pty) Ltd.as of 30 Sep 2022430.78k0.07%
More ▼
Data from 30 Sep 2022 - 30 Jan 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.